AstraZeneca announces ‘robust’ results from antibody-based Covid-19 drug trial
Pharmaceutical giant AstraZeneca on Thursday (November 18) announced that clinical trials of an antibody-based Covid-19 drug had shown robust efficacy and long-term prevention.
The Anglo-Swedish...